Literature DB >> 23892886

Improvement in hereditary hemorrhagic telangiectasia after treatment with the phosphoinositide 3-kinase inhibitor BKM120.

Urban W Geisthoff1, Ha-Long P Nguyen, Dagmar Hess.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23892886     DOI： 10.1007/s00277-013-1845-7

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  3 in total

1.  PI3K (Phosphatidylinositol 3-Kinase) Activation and Endothelial Cell Proliferation in Patients with Hemorrhagic Hereditary Telangiectasia Type 1.

Authors:  Adriana Iriarte; Agnes Figueras; Pau Cerdà; José María Mora; Anna Jucglà; Rosa Penín; Francesc Viñals; Antoni Riera-Mestre
Journal:  Cells       Date:  2019-08-24       Impact factor: 6.600

Review 2.  Future treatments for hereditary hemorrhagic telangiectasia.

Authors:  Florian Robert; Agnès Desroches-Castan; Sabine Bailly; Sophie Dupuis-Girod; Jean-Jacques Feige
Journal:  Orphanet J Rare Dis       Date:  2020-01-07       Impact factor: 4.123

Review 3.  Perioperative Complications and Long-Term Follow-Up of Liver Transplantation in Hemorrhagic Hereditary Telangiectasia: Report of Three Cases and Systematic Review.

Authors:  Antoni Riera-Mestre; Pau Cerdà; Yoelimar Carolina Guzmán; Adriana Iriarte; Alba Torroella; José María Mora-Luján; Jose Castellote; Amelia Hessheimer; Constantino Fondevila; Laura Lladó
Journal:  J Clin Med       Date:  2022-09-24       Impact factor: 4.964
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.